Key Pharmacologic Principles and Drug-Drug Interactions in HIV Patient Care
Summary
- Potential for antiarrhythmics to interact with all antiretrovirals; therefore, caution should be used upon coadministration
- Antiarrhythmics (eg, disopyramide, dofetilide, lidocaine, mexiletine, and propafenone) should not be coadministered with any ritonavir-boosted or cobicistat-boosted PI[DHHS ART]
- If unboosted atazanavir is coadministered, monitor for antiarrhythmic-related adverse events
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content
Keywords: Drug-Drug Interactions, Pharmacokinetics